Address: C76, Balewadi, Pune, Maharashtra
Uveitis is an eye inflammation affecting the middle layer of tissue in the eyewall. Some of the symptoms include pain, eye redness, and blurred vision. The condition can affect the lens, optic nerve, retina, and vitreous, creating reduced vision or blindness. Uveitis can be caused by an eye problem or due to other inflammatory diseases affecting other parts of the body. It can occur at all ages, and majorly affects people between 20-60 years old. The inflammation can be acute or chronic, and the severe form can reoccur.
Top Driver: Increasing Incidences of Uveitis and Introduction of New Treatment
The primary driver in the market is the increasing prevalence of uveitis and the complications concerning it. Also, rising investment in the research and development of new drugs and treatments and the emerging biologics is fueling the market growth. The introduction of a new treatment solution for uveitis, such as corticosteroids and anti-inflammatory drugs, are gaining traction in the market due to the promising results. Moreover, rapid approvals of drugs and new drug administration routes that enhance the efficacy of the drug are other factors proliferating the global uveitis treatment market.
On the other hand, the costly prices of medications and adverse effects of the medication, the lack of knowledge about eye disorders in developing countries, and the lack of health insurance are anticipated to hinder the market.
Corticosteroid Accounts for the Largest Market Share
Based on the treatment type, the market has been segmented into monoclonal antibodies, corticosteroids, antibiotics, and others. Among these, corticosteroids account for the largest market share owing to its good results—corticosteroid medicines aids in reducing inflammation. Various corticosteroid eye drops are approved by the Food and Drug Administration (FDA) as they are most commonly recommended by ophthalmologists. Based on the disease type, the market is segmented into intermediate uveitis, posterior uveitis, anterior uveitis, and pan uveitis. Based on the distribution channel, the market is segmented into retail, online, and hospital.
Rising Incidences and R & D Activities to Benefit North America Market
North America holds the largest market share owing to the rising incidence of non-infectious uveitis in the US. As many drugs are easily accessible in the US, thereby stimulating the country’s demand. This has encouraged increased R&D activities as well as increased healthcare expenditure. The rising geriatric population is also one of the major factors driving the market. Following North America, Asia Pacific is anticipated to create lucrative opportunities for the significant players.
Players to Focus on Uveitis treatment market
The market is anticipated to stay fragmented due to the increasing number of new entrants in the coming years. Few of the key companies operating in uveitis treatment market include Bausch & Lomb, Novartis AG, EyeGate, Santen Pharmaceutical Co., Ltd, EyePoint Pharmaceuticals, ALLERGAN, Alimera Sciences, Regeneron Pharmaceuticals, Wize Pharma Inc., Enzo Biochem Inc., and Alcon Inc.
Bausch Health Companies Inc.: In October 2019, Bausch Health Companies Inc. announced today that an affiliate of Bausch Health acquired an exclusive license for the commercialization and development of XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in the United States and Canada. XIPERE is a proprietary suspension of the corticosteroid triamcinolone acetonide formulated for suprachoroidal administration.
EyePoint Pharmaceutical: Feb. 04, 2019, EyePoint Pharmaceuticals, Inc. commercially launched YUTIQTM in the United States. YUTIQ is for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Besides, the Company has also introduced EyePoint Assist, a program to ensure access to YUTIQ for eligible patients in need of financial assistance.
By Treatment
By Disease type
By Distribution
By Region
Key Reasons to Purchase this Report
Chapter 2 Our Research Practice
Chapter 4 Covid-19 Impact Analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Sleep Apnea Devices Market Forces
5.2 Porter’s Five Forces Analysis
5.2.2 Threats From New Entrants
5.2.4 Threat From Substitute Product
Chapter 6 Global Sleep Apnea Devices Market -Industry Snapshots
6.1.1 Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
6.2.2 Restraint/Challenges analysis
6.3 Supply Chain/Value Chain Analysis
Chapter 7 Global Sleep Apnea Devices Market Analysis, by Diagnostic Devices
7.2 Key Findings for Sleep Apnea Devices Market- By Diagnostic Devices
7.2.1 Sleep Apnea Devices Market- Pulse oximeters
7.2.2 Sleep Apnea Devices Market- Actigraphy devices
7.2.3 Sleep Apnea Devices Market- Polysomnography Devices
Chapter 8 Global Sleep Apnea Devices Market Analysis, by Therapeutic Devices
8.2 Key Findings for Sleep Apnea Devices Market- By Therapeutic Devices
8.2.1 Sleep Apnea Devices Market- Oxygen Devices
8.2.2 Sleep Apnea Devices Market- Positive Airways Pressure Devices
8.2.3 Sleep Apnea Devices Market- Oral Appliances
8.2.4 Sleep Apnea Devices Market- Others
Chapter 9 Sleep Apnea Devices Market Analysis by Region
9.1 Key Findings for Sleep Apnea Devices Market- By region
9.2.1 Global Sleep Apnea Devices Market Analysis, By Diagnostic Devices, 2019 – 2028
9.2.2 Global Sleep Apnea Devices Market Analysis, By Therapeutic Devices, 2019 – 2028
9.3 Sleep Apnea Devices Market – North America
9.3.5 North America Market, By Diagnostic Devices
9.3.6 North America Market, By Therapeutic Devices
9.4 Sleep Apnea Devices Market – Europe
9.4.7 Europe Market, By Diagnostic Devices
9.4.8 Europe Market, By Therapeutic Devices
9.5 Sleep Apnea Devices Market – Asia Pacific
9.5.6 Asia Pacific Market, By Diagnostic Devices
9.5.7 Asia Pacific Market, By Therapeutic Devices
9.6 Sleep Apnea Devices Market – SAMEA
9.6.2 Middle East & Africa (MEA)
9.6.5 South America, Middle East and Africa Market, By Diagnostic Devices
9.6.6 South America, Middle East and Africa Market, By Therapeutic Devices
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
Chapter 11 Company Profiles- Snapshot
11.4 Fisher & Paykel Healthcare
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies”
List of Figures
FIG. 1 Global Sleep Apnea Devices: Market Segmentation
FIG. 2 Global Sleep Apnea Devices Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 5 Porter’s Five Forces Analysis
FIG. 6 Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Sleep Apnea Devices Market Value Contribution, By Diagnostic Devices, 2019 & 2026 (%)
FIG. 9 Global Sleep Apnea Devices Market Value Contribution, By Therapeutic Devices, 2019 & 2026 (%)
FIG. 10 Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 11 North America Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 12 Sleep Apnea Devices Market Segment 1 – North America
FIG. 13 Sleep Apnea Devices Market Segment 2 – North America
FIG. 14 Sleep Apnea Devices U.S. outlook, 2019 & 2026
FIG. 15 Sleep Apnea Devices Canada outlook, 2019 & 2026
FIG. 16 Sleep Apnea Devices Mexico outlook, 2019 & 2026
FIG. 17 Europe Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 18 Sleep Apnea Devices Market Segment 1 – Europe
FIG. 19 Sleep Apnea Devices Market Segment 2 – Europe
FIG. 20 Sleep Apnea Devices Germany outlook, 2019 & 2026
FIG. 21 Sleep Apnea Devices United Kingdom outlook, 2019 & 2026
FIG. 22 Sleep Apnea Devices France outlook, 2019 & 2026
FIG. 23 Sleep Apnea Devices Italy outlook, 2019 & 2026
FIG. 24 Sleep Apnea Devices Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 26 Sleep Apnea Devices Market Segment 1 – Asia Pacific
FIG. 27 Sleep Apnea Devices Market Segment 2 – Asia Pacific
FIG. 28 Sleep Apnea Devices China outlook, 2019 & 2026
FIG. 29 Sleep Apnea Devices Japan outlook, 2019 & 2026
FIG. 30 Sleep Apnea Devices India outlook, 2019 & 2026
FIG. 31 Sleep Apnea Devices Rest of APAC outlook, 2019 & 2026
FIG. 32 SAMEA Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)
FIG. 33 Sleep Apnea Devices Market Segment 1 – SAMEA
FIG. 34 Sleep Apnea Devices Market Segment 2 – SAMEA
FIG. 35 Sleep Apnea Devices Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Sleep Apnea Devices South America outlook, 2019 & 2026
FIG. 37 Sleep Apnea Devices Rest Of World outlook, 2019 & 2026
List of Tables
TABLE 1 Sleep Apnea Devices market by Diagnostic Devices 1, 2019 – 2028 (USD Million)
TABLE 2 Sleep Apnea Devices market by Diagnostic Devices 2, 2019 – 2028 (USD Million)
TABLE 3 Sleep Apnea Devices market by Diagnostic Devices 3, 2019 – 2028 (USD Million)
TABLE 4 Sleep Apnea Devices market by Therapeutic Devices 1, 2019 – 2028 (USD Million)
TABLE 5 Sleep Apnea Devices market by Therapeutic Devices 2, 2019 – 2028 (USD Million)
TABLE 6 Sleep Apnea Devices market by Therapeutic Devices 3, 2019 – 2028 (USD Million)
TABLE 7 Sleep Apnea Devices market by Therapeutic Devices 4, 2019 – 2028 (USD Million)
TABLE 8 Global Sleep Apnea Devices Market Value, By Diagnostic Devices, 2019 – 2028 (US$ Bn)
TABLE 9 Global Sleep Apnea Devices Market Value, By Therapeutic Devices, 2019 – 2028 (US$ Bn)
TABLE 10 Sleep Apnea Devices Market Analysis by North America (USD Million), 2019 – 2028
TABLE 11 U.S. Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 12 U.S. Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 13 U.S. Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 14 Canada Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 15 Canada Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 16 Canada Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 17 Mexico Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 18 Mexico Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 19 Mexico Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 20 Sleep Apnea Devices Market Analysis by Europe (USD Million), 2019 – 2028
TABLE 21 Germany Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 22 Germany Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 23 Germany Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 24 United Kingdom Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 25 United Kingdom Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 27 France Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 28 France Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 29 France Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 30 Italy Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 31 Italy Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 32 Italy Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 33 Rest Of Europe Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 34 Rest Of Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 36 Sleep Apnea Devices Market Analysis by Asia Pacific (USD Million), 2019 – 2028
TABLE 37 China Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 38 China Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 39 China Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 40 Japan Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 41 Japan Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 42 Japan Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 43 India Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 44 India Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 45 India Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 46 Rest of APAC Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 47 Rest of APAC Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 48 Rest of APAC Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 49 Sleep Apnea Devices Market Analysis by SAMEA (USD Million), 2019 – 2028
TABLE 50 Middle East & Africa (MEA) Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 53 South America Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 54 South America Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 55 South America Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
TABLE 56 Rest Of World Sleep Apnea Devices Market, 2019 – 2028 (USD Million)
TABLE 57 Rest Of World Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)
TABLE 58 Rest Of World Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)
Please fill out the form to receive sample pages of the report